ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
38.10
0.00%
US Tech 100
19,396.37
-0.09%
S&P 500
5,732.93
0.00%
US Dollar vs CAD
1.34398
0.14%
Bitcoin
63,685.33
-0.91%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Applied Therapeutics Inc (APLT) Share Price

Applied Therapeutics Inc

Applied Therapeutics Inc (APLT)

NASDAQ
8.105
0.43
(5.53%)
Closed September 24 3:00PM
Delayed by 15 minutes
7.9137
-0.1913
( -2.36% )
Pre Market: 7:31AM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
7.9137
Bid
8.02
Ask
8.12
Volume
1,036
0.00 Day's Range 0.00
1.79 52 Week Range 9.39
Market Cap
908.859M
Previous Close
8.105
Open
-
Last Trade
50
@
8.0104
Last Trade Time
07:26:13
Financial Volume
-
VWAP
-
Average Volume (3m)
2,287,224
Shares Outstanding
114,846,271
Dividend Yield
-
PE Ratio
-7.77
Earnings Per Share (EPS)
-1.04
Revenue
9.99M
Net Profit
-119.76M

About Applied Therapeutics Inc

Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The lead product candidate of the company is AT-001, which is a novel ARI with broad systemic expos... Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The lead product candidate of the company is AT-001, which is a novel ARI with broad systemic exposure and peripheral nerve permeability, developed for the treatment of diabetic cardiomyopathy, or DbCM, a fatal fibrosis of the heart. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.appliedtherapeutics.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Applied Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker APLT. The last closing price for Applied Therapeutics was US$8.11. Over the last year, Applied Therapeutics shares have traded in a share price range of US$ 1.79 to US$ 9.39.

Applied Therapeutics currently has 114,846,271 shares outstanding. The market capitalization of Applied Therapeutics is US$930.83 million. Applied Therapeutics has a price to earnings ratio (PE ratio) of -7.77.

Ask ADVFN Intelligence (AI)

Applied Therapeutics (APLT) Options Flow Summary

APLT Options Flow

Overall Flow

Bullish

Net Premium

139k

Calls / Puts

166.67%

Buys / Sells

33.33%

OTM / ITM

14.29%

Sweeps Ratio

0.00%

APLT Latest News

More News

Applied Therapeutics Provides Regulatory Update on Govorestat for the Treatment of Classic Galactosemia

- Company completed Late-Cycle review meeting with FDA - FDA no longer intends to hold Advisory Committee meeting - FDA Review of NDA continues to proceed as planned with PDUFA target action...

September 18 2024
GlobeNewswire Inc.

Applied Therapeutics to Participate in Upcoming Investor Conferences

NEW YORK, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against...

September 04 2024
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

August 23 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

August 23 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

August 14 2024
Edgar (US Regulatory)

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

August 14 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

August 09 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

August 07 2024
Edgar (US Regulatory)

Form 8-K - Current report

August 07 2024
Edgar (US Regulatory)

Applied Therapeutics Reports Second Quarter 2024 Financial Results

NDA and MAA for govorestat for treatment of Classic Galactosemia under FDA Priority Review and EMA review; PDUFA target action date of November 28, 2024, and EMA decision expected in early Q1...

August 07 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
11.403721.56221198166.518.86916.5152833247.85257886CS
41.793729.30882352946.128.86914.5548210667.449493CS
123.563781.9241379314.358.86914.3122872246.91820295CS
261.393721.37576687126.528.86913.9515969836.21003526CS
525.1937190.9448529412.729.391.7916001915.09387765CS
156-7.8563-49.818008877615.7719.140.49957728734.1751034CS
260-2.0063-20.22479838719.9257.390.49955189197.0892189CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
OCTOEightco Holdings Inc
US$ 3.75
(50.60%)
9.38M
BREABrera Holdings PLC
US$ 0.9499
(30.12%)
5.46M
ELYMEliem Therapeutics Inc
US$ 8.32
(26.83%)
1.12M
MSGMMotorsport Games Inc
US$ 1.35
(22.73%)
5.39M
VSMEVS Media Holdings Ltd
US$ 1.48
(20.33%)
4.11M
VTNRVertex Energy Inc
US$ 0.1481
(-58.98%)
4.02M
BNZIBanzai International Inc
US$ 5.40
(-34.47%)
469.67k
SFIXStitch Fix Inc
US$ 2.799
(-25.36%)
191.45k
THTarget Hospitality Corporation
US$ 7.16
(-24.15%)
155.74k
PLUSePlus inc
US$ 78.00
(-20.36%)
5
STSSSharps Technology Inc
US$ 0.15
(-12.02%)
14.28M
ELABElevai Labs Inc
US$ 0.1062
(3.11%)
9.72M
OCTOEightco Holdings Inc
US$ 3.75
(50.60%)
9.38M
SEELSeelos Therapeutics Inc
US$ 0.325
(8.70%)
8.8M
AIMDAinos Inc
US$ 0.5337
(10.73%)
6.67M

APLT Discussion

View Posts
Invest-in-America Invest-in-America 7 days ago
APLT: 200%-up, for sure today.
👍️0
Awl416 Awl416 1 week ago
Applied Therapeutics Provides Regulatory Update on Govorestat for the Treatment of Classic Galactosemia
👍️0
Monksdream Monksdream 3 weeks ago
APLT under $7
👍️0
Monksdream Monksdream 5 months ago
APLT under $5
👍️0
InvestorPhilia4 InvestorPhilia4 6 months ago
I have held this for several years and there are many prospects progressing. I like the significant CEO ownership position.
👍️0
Monksdream Monksdream 7 months ago
APLT new 52 week high
👍️0
Monksdream Monksdream 7 months ago
APLT new 52 week high
👍️0
ddt60 ddt60 7 months ago
Outstanding
👍️0
Awl416 Awl416 7 months ago
Applied Therapeutics Announces $100 Million Private Placement
👍️0
Nadendla Nadendla 7 months ago
OMG.. really..
👍️0
Nadendla Nadendla 7 months ago
yup.. my mistake that i overlooked you.. you will financial crisis for the next 3 years..
👍️0
TrendTrade2016 TrendTrade2016 7 months ago
APLT what a beast and not one ihubber talking. The best kind!
👍️0
TrendTrade2016 TrendTrade2016 7 months ago
APLT...NEXT MONSTER BIO BEAST!!!
👍️0
TrendTrade2016 TrendTrade2016 7 months ago
APLT...HUGE BREAK OUT PLAY
👍️0
TrendTrade2016 TrendTrade2016 9 months ago
APLT..THE NEXT BIO BEAST THAT WILL BEAST THROUGH BEASTVILLE
👍️0
TrendTrade2016 TrendTrade2016 9 months ago
APLT...4.47 HERE WE COME
👍️0
TrendTrade2016 TrendTrade2016 9 months ago
APLT...ANOTHER MONSTER IN THE MAKING
👍️0
TrendTrade2016 TrendTrade2016 9 months ago
APLT..HERE WE GO
👍️0
TrendTrade2016 TrendTrade2016 9 months ago
APLT STRONG TREND IN PLACE
👍️0
ddt60 ddt60 9 months ago
Maybe this could run back up to where it was 4 years ago.
👍️0
TrendTrade2016 TrendTrade2016 9 months ago
APLT...HERE WE GO
👍️0
TrendTrade2016 TrendTrade2016 9 months ago
APLT READY TO BLOW UP ONCE AGAIN
👍️0
stock1ace1 stock1ace1 9 months ago
Aplt $3.10 pending news
👍️0
TrendTrade2016 TrendTrade2016 1 year ago
back in on break out
👍️0
TrendTrade2016 TrendTrade2016 1 year ago
APLT...THE MONSTER IS RUNNING HARD NOW
👍️0
TrendTrade2016 TrendTrade2016 1 year ago
APLT..HERES THE BREAK OUT...WEEKLY TRAND IN PLACE LIKE YOU HAVE NEVER SEEN
👍️0
TrendTrade2016 TrendTrade2016 1 year ago
APLT HAS THE BEST WEEKLY CHART OF ANY BIO OUT THERE
👍️0
halbroke1 halbroke1 1 year ago
Trend $$$ Great Pick with APLT $$$, I agree 100% here... Could easily Go To $10.00+ or Higher....EOD & After_Hours could get Wild..
👍️0
TrendTrade2016 TrendTrade2016 1 year ago
wowza...look at her go
👍️0
TrendTrade2016 TrendTrade2016 1 year ago
APLT...READY FOR 2.67...MONSTER
👍️0
TrendTrade2016 TrendTrade2016 1 year ago
APLT MONSTER IN THE MAKING...WEEKLY BLOW OUT TREND IN PLACE
👍️0
TrendTrade2016 TrendTrade2016 1 year ago
APLT BIO BEAST READY TO BEAST
👍️0
81vette 81vette 1 year ago
took the news a few days to sink in,no date yet on fda meeting(says,this summer smh) ema marketing application in fall for other drug,update is good,just a bit more time
👍️0
tw0122 tw0122 1 year ago
Up up some
👍️0
81vette 81vette 2 years ago
Buy rating $23-$29 Citigroup,the Barclays $7-$9 is more believable,omg the greed will be strong,any hint of fda news like fast track will make heads explode lol
👍️0
81vette 81vette 2 years ago
Pps above 200ma,golden cross coming ,greatest long chart indicator ever,macd about to cross bullish line,short algos wouldn’t touch a ticker like this and shorts gotta cover! Lions tigers and bulls OHHH MYYY!!!
👍️0
81vette 81vette 2 years ago
Look at what happens with green vol on 1 year chart below,high reward/no risk in past,that’s amazing!!! Every time up !!
👍️0
81vette 81vette 2 years ago
Trading natural/no naked shorting atm
👍️0
81vette 81vette 2 years ago
Pre mkt today$1.40ish/$1.25ave,tonight and tomorrow continues up as word spreads and scanners blowing up
👍️0
81vette 81vette 2 years ago
Looking good for week long run like in past with near record volume
👍️0

Your Recent History

NASDAQ
APLT
Applied Therapeutics
BIT
UC1MWL
Unicredit Bank
TG
S3T
Shutterstock
BIT
UB2AZD
UniCredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved